We report an improved synthesis of cis -[Ru(CH 3 CN) 2 ((1−3-η)-C 3 H 5 )((1,2:5,6-η)-C 8 H 12 )]BF 4 and its use in the synthesis of [Ru(bisphosphine)((1−3:5,6-η)-C 8 H 11 )(CH 3 CN)]BF 4 (where bisphosphine = ( R )-BINAP, ( R )-Tol-BINAP). Thermolyses of the complexes [Ru(bisphosphine)((1−3:5,6-η)-C 8 H 11 )(CH 3 CN)]BF 4 afford [Ru(bisphosphine)((1−5-η)-C 8 H 11 )]BF 4, which serve as convenient precatalysts to the active hydrogenation catalysts fac -[Ru(bisphosphine)(H)(sol) 3 ]BF 4 (sol = THF, acetone, i -PrOH). We compare the properties and activities of these catalysts with those of related, established systems.
No takes yet. Share an insight, caveat, or question.
Wiles et al. (2004) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: